[1]
Holtz, Z. et al. 2026. Sugammadex: Safety Profile and Adverse Effects in Infants Less Than Two Years of Age With Congenital Heart Disease. Cardiology Research. 17, 4 (Jan. 2026), 300–307. DOI:https://doi.org/10.14740/cr2243.